Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [<sup>18</sup>F]FDG PET-CT and relevance to study interpretation.

Cohen, Dan; Krauthammer, Shir Hazut; Wolf, Ido; Even-Sapir, Einat

Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [¹⁸F]FDG PET-CT and relevance to study interpretation.

Cohen, Dan; Krauthammer, Shir Hazut; Wolf, Ido; Even-Sapir, Einat.

Afiliação

Cohen D; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.
Krauthammer SH; Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.
Wolf I; Institute of Oncology, Tel-Aviv Sourasky Medical Center, 6 Weizmann St, 6423906, Tel Aviv, Israel.
Even-Sapir E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Eur J Nucl Med Mol Imaging ; 48(6): 1854-1863, 2021 06.

Article em En | MEDLINE | ID: mdl-33774684

Assuntos

COVID-19; Linfadenopatia; Vacina BNT162; Vacinas contra COVID-19; Fluordesoxiglucose F18; Humanos; Incidência; Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada; RNA Mensageiro; SARS-CoV-2

Palavras-chave

Axillary lymph nodes; Covid-19; False-positive [18F]FDG uptake; Oncologic imaging; Vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfadenopatia / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfadenopatia / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article